ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Turning Point Therapeutics Inc

Turning Point Therapeutics Inc (TPTX)

76.01
0.00
(0.00%)
Closed September 26 3:00PM
76.01
0.00
( 0.00% )
Pre Market: 7:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
76.01
Bid
71.11
Ask
72.20
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
76.01
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TPTX Latest News

Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics

Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) (“Turning Point”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...

Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational Updates

Positive feedback from pre-new drug application (NDA) meeting with U.S. Food and Drug Administration (FDA) focused on TRIDENT-1 registrational study of repotrectinibInitiated the Phase 1b/2...

Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC

SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer Therapies

HOUSTON and SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted...

Turning Point Therapeutics Shares Surge on Bristol Myers Deal

By Colin Kellaher Shares of Turning Point Therapeutics Inc. took flight on Friday after the clinical-stage precision-oncology company agreed to be acquired by Bristol Myers Squibb Co. for $4.1...

Bristol Myers to Buy Turning Point Therapeutics for $4.1 Billion

By Colin Kellaher Bristol Myers Squibb Co. on Friday said it agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Inc. for $4.1 billion, or $76 a share, in cash. The...

Turning Point Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics Reports First-Quarter 2022 Financial Results, Provides Operational Updates

Granted Third Breakthrough Therapy Designation (BTD) for Repotrectinib for the treatment of patients with ROS1-positive Metastatic NSCLC who have been Previously Treated with One ROS1 TKI and who...

Turning Point Gets Another FDA Breakthrough Designation for Repotrectinib

By Colin Kellaher Turning Point Therapeutics Inc. on Tuesday said the U.S. Food and Drug Administration granted breakthrough-therapy designation to its lead drug candidate, repotrectinib, for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ONCOOnconetix Inc
US$ 6.12
(82.39%)
7.8M
CNEYCN Energy Group Inc
US$ 0.9002
(55.23%)
19.85M
XPONExpion360 Inc
US$ 0.0852
(32.30%)
39.25M
DUOFangDD Network Group Ltd
US$ 1.41
(31.78%)
21.56M
RGFReal Good Food Company Inc
US$ 0.4855
(31.22%)
3.86M
HLPHongil Group Inc
US$ 0.905
(-49.86%)
10
LELands End Inc
US$ 13.84
(-17.81%)
516
NVNOenVVeno Medical Corporation
US$ 3.73
(-17.11%)
80.04k
AYTUAYTU BioPharma Inc
US$ 2.39
(-16.11%)
3.17k
MNTSMomentus Inc
US$ 0.4501
(-16.03%)
244.01k
XPONExpion360 Inc
US$ 0.0852
(32.30%)
39.25M
DUOFangDD Network Group Ltd
US$ 1.41
(31.78%)
21.56M
CNEYCN Energy Group Inc
US$ 0.9002
(55.23%)
19.85M
CDIOCardio Diagnostics Holdings Inc
US$ 0.2937
(17.48%)
11.31M
ONCOOnconetix Inc
US$ 6.12
(82.39%)
7.8M

Discussion

View Full Feed
coldest coldest 4 minutes ago
GET READY PEOPLE ! ARE YOU READY FOR BLASTOFF ! LOO
TPTW
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
Company does not have to put up any money
FNRC
RobotDroid RobotDroid 4 minutes ago
That's just a guess, and probably wrong.
NWBO
Katfish Katfish 4 minutes ago
Stocks with buying interest early AM:
DUO
CNEY
ATGL
CLSK
FFIE
IREN
BTBT
ATGL BTBT CLSK
Newly2b Newly2b 4 minutes ago
Thanks, Zorax. I didn't get charged nor was my RAV listed as a free trial. It certainly did come from Microsoft whatever they say. The scams people run these days are more and more sophisticated. This one apparently affected a large number of people, since, of course, most of us run windows and
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Maybe partner has no money or properties terrible
FNRC
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Working interesting
FNRC
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Interesting company
FNRC
TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 6 minutes ago
He expects billion dollar filings in a pink sheet company. That's why he can't make the money that we make on these.
AAPJ
PENNY DIPZ PENNY DIPZ 6 minutes ago
After the last note is paid in full, the “Held at DTC” number which is all that matters, will be less than 550 million shares which is insanely low.
SINC
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Terrible what happened here
FNRC
sloppyjones sloppyjones 6 minutes ago
A few more updates to the site. Looks like a swim meet with sponsor. Grenada.
TPTW
georgejjl georgejjl 6 minutes ago
Have you noticed the cost of this new drug treatment $22,000.00 per year.

US FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/bu
AVXL
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Great share structure
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Been going a long time
DCMDF
Ms Labonte Ms Labonte 6 minutes ago
Hit the bid$$ junkie$$ it’$ Friday beer and crack$$$$
RNAZ
surfkast surfkast 7 minutes ago
I believe Kay is about 75 now. Probably no desire to do anything here ever again. As for the others, I believe they see there is no future or they would have picked up the ball.
ZRFY
subslover subslover 7 minutes ago
NICE FIND!
CNEY
TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
Had r s a w while back
DCMDF
Jack_Bolander Jack_Bolander 7 minutes ago
More Bad News :


https://www.ecoticias.com/en/pipelines-hydrogen-blending/6648/



PLUG
TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
Had r s a w while back
DCMDF
Ms Labonte Ms Labonte 8 minutes ago
Rolling in the sixtee$$$ $weet$$
WEET
infamous infamous 8 minutes ago
753mil OS lol and just wait until those 373mil shares become UNRESTRICTED! guess what. when theres a RS, they keep the AS the SAME. Dilution at its finest!
ATWT
1vman 1vman 8 minutes ago
*****🅰️🅰️🅰️ Now I am hearing HCMC is going to be bought out -- LOL !!! No one wants this stinky OTC pinky , This company has nothing left after spin off

https://investorshub.advfn.com/uimage/uploads/2024/9/12/ypv
HCMC
Jack_Bolander Jack_Bolander 8 minutes ago
Interesting :


The Dark Side of Hydrogen Cars https://www.youtube.com/watch?v=cEJi1erkZeo

PLUG